Human hepatitis B immunoglobulin (Sichuan Yuanda Shuyang Pharmaceutical)

人乙型肝炎免疫球蛋白（四川远大蜀阳）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman hepatitis B immunoglobulin (Sichuan Yuanda Shuyang Pharmaceutical)
Drug Alias Name人乙肝免疫球蛋白（四川远大蜀阳）
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2008/02/04
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A